Based on the earnings call transcript, the following points are relevant for the short-term (1â€“2 weeks) impact on UnitedHealth Group's stock price:

1. **COVID-19 Impact**: The company highlighted the significant impact of COVID-19 on its operations and financials, noting that the first quarter financial impact was limited but anticipating a more significant impact in the coming quarters.

2. **Financial Guidance**: Despite the uncertainty, the company maintained its full-year 2020 earnings per share outlook. However, it acknowledged that key investor conference metrics may play out differently than expected.

3. **Operational Resilience**: UnitedHealth Group emphasized its operational resilience and ability to adapt to the crisis, with a focus on maintaining service levels and ensuring the well-being of its employees and communities.

4. **Commitment to Financial Stability**: The company committed to ensuring financial imbalances arising from the situation are reconciled proactively and fairly for all those they serve.

5. **Strategic Initiatives**: The company highlighted several strategic initiatives, including enhancements in digital health and virtual care delivery, which could position it well for the post-COVID-19 era.

Given these factors, the short-term impact on the stock price is likely to be neutral to slightly positive, as investors may appreciate the company's operational resilience, financial stability, and strategic initiatives. However, the uncertainty surrounding the COVID-19 pandemic and its potential impact on the company's financials could also introduce some volatility in the stock price.

**Rating: 0**